http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2141325-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_459efa113667021a12b7f3956f89af0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17c04cfd5a60686e5580f0a8c1644f97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69726a2d5019ea6faa093015016f67aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83e057072784ac2b4d12bd90489c08b5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30 |
| filingDate | 1999-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b260791d541fbe97e268d119f251fca6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f08aea316066bc6c1fac47f367563fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbfd862212109b458dbc853e294f7edf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ecf2719aa24f36900d4e01b648124da |
| publicationDate | 1999-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2141325-C1 |
| titleOfInvention | Method of treatment of patients with posttraumatic immunodeficiency in acute period of brain traumatic disease |
| abstract | FIELD: medicine. SUBSTANCE: method involves the use of the bioregulating agent epytalamine in addition to the course of the conventional complex intense therapy. Epytalamine is administrated at severe craniocerebral trauma by endolumbar route at the dose 20 mg dissolved in 1.5-5 ml of 10% glucose solution for 3 days. Then the preparation is administrated intravenously at the dose 20 mg in every 24 h for 7 days. Method provides the recovery of damaged neuroregulation of immunogenesis in the brain after trauma by modulation of the functional activity of hypothalamus-hypophysis system. Method can be used in neurotraumatology and neuroreanimatology in the complex treatment of patients with the brain traumatic disease. EFFECT: improved method of treatment, enhanced effectiveness of treatment. 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2470676-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2477150-C2 |
| priorityDate | 1999-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.